Investing.com - Achieve Life Sciences (NASDAQ: ACHV) reported first quarter EPS of $-0.830, $0.21 better than the analyst estimate of $-1.040. Revenue for the quarter came in at $0.00 versus the consensus estimate of $125K.
Achieve Life Sciences's stock price closed at $4.440. It is up 77.600% in the last 3 months and down -35.650% in the last 12 months.
Achieve Life Sciences saw 4 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Achieve Life Sciences's stock price’s past reactions to earnings here.
According to InvestingPro, Achieve Life Sciences's Financial Health score is "weak performance".
Check out Achieve Life Sciences's recent earnings performance, and Achieve Life Sciences's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar